to-BBB, the brain drug delivery company, is pleased to announce the successful completion of its 2B3-101 Phase I part of its clinical trial in brain cancer patients, safely reaching clinically effective dosages. to-BBB is now ready to proceed to the Phase IIa part of this trial, treating...
NeuroVive Pharmaceutical and to-BBB, the Dutch drug brain delivery company, are entering into a joint program to develop therapies for stroke and other acute neurodegenerative diseases by combining their technologies. NeuroVive Pharmaceutical is engaged in research and development of nerve...